Rapid tumor development with a modified MCF-7 xenograft model
Hale, L.V.; Layman, N.K.; Wilson, P.; Short, L.L.; Magee, D.E.; Wightman, S.R.; Fuchs-Young, R.
Laboratory Animal Science 47(1): 82-85
1997
ISSN/ISBN: 0023-6764 PMID: 9051652 Document Number: 474519
Document emailed within 1 workday
Related Documents
Wang, Z.; Zhu, Z. 2017: Application and development of patient-derived tumor xenograft model in translational medicine of tumor Zhonghua Wei Chang Wai Ke Za Zhi 20(5): 596-600Van der Jagt, R.H.; Badger, C.C.; Appelbaum, F.R.; Press, O.W.; Matthews, D.C.; Eary, J.F.; Krohn, K.A.; Bernstein, I.D. 1992: Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model Cancer Research 52(1): 89-94
Yamasaki, A.; Shoda, M.; Iijima, H.; Nagai, S.; Wada, J.; Suzuki, H.; Chikazawa, N.; Tasaka, T.; Kameda, C.; Tanaka, H.; Ikebe, M.; Jo, E.; Sato, N.; Nakamura, M.; Sekine, F.; Morisaki, T.; Katano, M. 2009: A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model Anticancer Research 29(3): 843-850
Kocheril, S.V.; Grignon, D.J.; Wang, C.Y.; Maughan, R.L.; Montecillo, E.J.; Talati, B.; Tekyi-Mensah, S.; Pontes, J.e.; Hillman, G.G. 1999: Responsiveness of human prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model Cancer Detection and Prevention 23(5): 408-416
Rajmani, R.S.; Singh, P.K.; Kumar, S.; Kumar, G.R.; Sahoo, A.P.; Santra, L.; Saxena, S.; Singh, L.V.; Chaturvedi, U.; Saxena, L.; Desai, G.S.; Gupta, S.K.; Kumar, A.; Jadon, N.S.; Tiwari, A.K. 2014: Development of dog mammary tumor xenograft in immunosuppressed Swiss albino mice Indian Journal of Experimental Biology 52(10): 935-942
Delacollette, C.; Stuyft, P. van der; Barutwanayo, M. 1993: Development of a simple and reliable method for estimating malaria morbidity according to the modified Muench model Revue d'Epidemiologie et de Sante Publique 41(5): 416-421
Zhang, X.; Wu, J.; Gao, D.; Fei, Z.; Qu, Y.; Jing, J. 2002: Development of a rat C6 brain tumor model Chinese Medical Journal 115(3): 455-457
Tanaka, N.; Kojima, K.; Muro, M.; Naomoto, Y.; Moreira, L.F.; Orita, K. 1995: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft Anticancer Research 15(5b): 1949-1952
Jamieson, S.W. 1974: Xenograft hyperacute rejection. a new model Transplantation 17(5): 533-534
Pauli, B.U.; Anderson, S.N.; Memoli, V.A.; Kuettner, K.E. 1980: Development of an in vitro and in vivo epithelial tumor model for the study of invasion Cancer Research 40(12): 4571-4580
Olszewski, W. 1973: Rabbit-to-dog liver xenograft as a model for study of the process of hyperacute rejection Acta Medica Polona 14(2): 107-111
Ji, M.; Wang, L.-y.; Lü, Y.-h.; Lai, F.-f.; Chen, X.-g. 2016: Establishment of a glioma orthotopic xenograft model based on imaging technology Yao Xue Xue Bao 51(8): 1245-1249
Sudra, G.; Speidel, S.; Platzek, S.; Müller-Stich, B.P.; Dillmann, R. 2008: Augmented reality assistance for realization of incision planning and model-based analysis of the modified surface model Studies in Health Technology and Informatics 132: 505-507
Pinto, M.E.; Nelson, R.A. 1975: The effect of antibody and complement on perfused hearts: a model for the study of xenograft rejection phenomenon Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 149(1): 78-93
Rutgers, M.; Gubbels, A.A.; Hoefnagel, C.A.; Voûte, P.A.; Smets, L.A. 1991: A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy Progress in Clinical and Biological Research 366: 471-478
Velders, M.P.; van Rhijn, C.M.; Briaire, I.H.; Fleuren, G.J.; Warnaar, S.O.; Litvinov, S.V. 1995: Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model Cancer Research 55(19): 4398-4403
Kubo, O.; Kitamura, K.; Wechsler, W. 1983: Xenotransplantation of human brain tumor into nude mice--morphological changes of the xenograft No Shinkei Geka. Neurological Surgery 11(4): 369-377
Brouard, S.; Cuturi, M.C.; Pignon, P.; Buelow, R.; Loth, P.; Moreau, A.; Soulillou, J.P. 1999: Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide Transplantation 67(12): 1614-1618
Kawamura, T.; Endo, Y.; Yonemura, Y.; Nojima, N.; Fujita, H.; Fujimura, T.; Obata, T.; Yamaguchi, T.; Sasaki, T. 2001: Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model International Journal of Oncology 18(4): 809-815
Znati, C.A.; Rosenstein, M.; Boucher, Y.; Epperly, M.W.; Bloomer, W.D.; Jain, R.K. 1996: Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft Cancer Research 56(5): 964-968